1 The eects of the voltage-dependent calcium channel (VDCC) blockers o-agatoxin IVA (o-AgaIVA), o-conotoxin GVIA (o-CgTx), o-conotoxin MVIIC (o-MVIIC) and o-conotoxin MVIID (o-MVIID) were evaluated on transmitter release in the mouse diaphragm preparation. The eects of o-AgaIVA and o-MVIIC were also evaluated on the perineurial calcium and calcium-dependent potassium currents, I Ca and I K(Ca) , respectively, in the mouse levator auris preparation. 2 The P-and Q-type VDCC blocker o-AgaIVA (100 nM) and P-Q-and N-type channel blockers o-MVIIC (1 mM) and o-MVIID (3 mM) strongly reduced transmitter release (480 ± 90% blockade) whereas the selective N-type channel blocker o-CgTx (5 mM) was ineective. 3 The process of release was much more sensitive to o-MVIIC (IC 50 =39 nM) than to o-MVIID (IC 50 =1.4 mM). After almost completely blocking transmitter release (quantal content *0.3% of its control value) with 3 mM o-MVIIC, elevating the external [Ca 2+ ] from 2 to 10 mM induced an increase of *20 fold on the quantal content of the endplate potential (e.p.p.) (from 0.2+0.04 to 4.8+1.4). 4 Nerve-evoked transmitter release in a low Ca 2+ -high Mg 2+ medium (low release probability, quantal content = 2+0.1) had the same sensitivity to o-AgaIVA (IC 50 =16.8 nM) as that in normal saline solutions. In addition, K + -evoked transmitter release was also highly sensitive to the action of this toxin (IC 50 =11.5 nM; 100 nM 495% blockade). The action of o-AgaIVA on transmitter release could be reversed by toxin washout if the experiments were carried out at 31 ± 338C. Conversely, the eect of oAgaIVA persisted even after two hours of toxin washout at room temperature. 5 Both the calcium and calcium-dependent potassium presynaptic currents, I Ca and I K(Ca) , respectively, were highly sensitive to low concentrations (10 ± 30 nM) of o-AgaIVA. The I Ca and the I K(Ca) were also strongly reduced by 1 mM o-MVIIC. The most marked dierence between the action of these two toxins was the long incubation times required to achieve maximal eects with o-MVIIC. 6 In summary these results provide more evidence that synaptic transmission at the mammalian neuromuscular junction is mediated by Ca 2+ entry through P-and/or Q-type calcium channels.
Introduction
Voltage-dependent calcium channels (VDCC) play a key role in neuronal signalling as mediators of Ca 2+ entry during the process of transmitter release (Katz, 1969; LlinaÂ s et al., 1976; Augustine & Charlton, 1986) . Biophysical and pharmacological studies together with molecular cloning strategies have led to the identi®cation of various VDCC types (Nowycky et al., 1985; Bean, 1989; LlinaÂ s et al., 1992; Zhang et al., 1993) . Toxins extracted from the venom of predator species whose strategy involves paralysing their prey, like the ®sh-hunting snails and insect-hunting spiders, have been found to target selectively many of these VDCC (Olivera et al., 1994) . These natural toxins, together with their synthetic counterparts and molecular variants, have become invaluable tools in the identi®cation of the role of dierent VDCC in central and peripheral synaptic transmission in many species (see Olivera et al., 1994; Dunlap et al., 1995) . Based on biophysical and pharmacological characteristics, VDCC have been classi®ed into the T-, L-, N-, P-, Q-and R-types (Nowycky et al., 1985; Bean, 1989; LlinaÂ s et al., 1992; Zhang et al., 1993) . The L-, N-, P-and Q-type channels, all of which require high voltages to activate, have been shown to participate in the process of release in several systems. L-type channels, can be identi®ed by their high sensitivity to dihydropyridines while the N-, P-and Q-type channels, which are all insensitive to dihydropyridines, can be further discriminated based on their dierential sensitivity to neurotoxins (Olivera et al, 1994; Dunlap et al., 1995) . N-type channels are speci®cally targeted by o-conotoxin GVIA (o-CgTx), a polypeptide puri®ed from the venom of the marine snail Conus geographus (Olivera et al., 1984) . P-type channels, are strongly antagonized by the funnel-web spider toxin (FTX) and by o-agatoxin IVA (o-AgaIVA), a low molecular weight fraction and a polypeptide, respectively, both puri®ed from the venom of the funnel-web spider Agelenopsis aperta (LlinaÂ s et al., 1989; Mintz et al., 1992a,b) . Q-type channels, which are closely related to the P-type channels from the molecular point of view (Stea et al., 1994; Westenbroek et al., 1995) , are also blocked by o-AgaIVA. However, they can be discriminated from the P-type channels by their lower sensitivity to this toxin and by their much higher degree of inactivation (Zhang et al., 1993; Randall & Tsien, 1995) . Two other conotoxins which target P-, Q-and N-type channels, oconotoxin MVIIC (o-MVIIC) and o-conotoxin MVIID (o-MVIID), have been identi®ed from cDNA libraries made from the venom duct of the marine snail Conus magus. These two synthetic toxins were found to bind with high anity to both the`N-type' and the`non N-type' sites in rat brain membranes (Hillyard et al., 1992; Monje et al., 1993) and to inhibit K + -evoked Ca 2+ uptake from rat brain synaptosomes (Hillyard et al., 1992; Monje et al., 1993; Alvarez-Maubecin et al., 1995) . In addition, o-MVIIC has been shown to be a potent blocker of synaptic transmission both at the central (Wheeler et al., 1994a) and peripheral nervous system (Bowersox et al., 1995; Sugiura et al., 1995; Lin & Lin Shiau, 1995; Wright & Angus, 1996) . The eects of o-MVIID on synaptic transmission have not been studied so far. At the mature mammalian neuromuscular junction, VDCC of the P-type family (P/Q) seem to be the only VDCC involved in nerve-evoked transmitter release. This assumption is based on the inhibitory eects of FTX (Uchitel et al., 1992) , o-AgaIVA (Protti & Uchitel, 1993; Hong & Chang, 1995; Bowersox et al, 1995; Protti et al., 1996; Wright & Angus, 1996; Katz et al., 1996) and o-MVIIC (Bowersox et al., 1995; Sugiura et al., 1995; Wright & Angus, 1996 and on the lack of eects of the N-and L-type channel blockers, o-CgTx (Anderson & Harvey, 1987; Sano et al., 1987; Protti et al., 1991; Wright & Angus, 1996 ; but see Rossoni et al., 1994) and dihydropyridines (Penner & Dryer, 1986; Atchinson, 1989; Katz et al., 1996) , respectively. In order to characterize further the type/s of VDCC involved in neuromuscular transmission in mammals, we studied the eects of o-CgTx, o-MVIIC, o-MVIID and o-AgaIVA on transmitter release at the mouse neuromuscular junction. The actions of oAgaIVA and o-MVIIC were also evaluated on presynaptic currents in order to correlate the pharmacological pro®le of transmitter release with that of VDCC present at these motor terminals.
Methods
Experiments were carried out on either the diaphragm (for studying transmitter release) or the levator auris longus (for studying perineurial currents) muscles of adult male Swiss mice weighing 20 ± 30 g. Animals were anaesthetized with an overdose of 2% tribromoethanol (0.3 ± 0.5 ml 10 g 71 body wt; i.p.) and immediately exsanguinated. The corresponding muscle with its nerve supply was excised and dissected on a Sylgardcoated Petri dish containing a physiological saline solution (normal saline) of the following composition (mM): NaCl 137, KCl 5, CaCl 2 2, MgSO 4 1, NaHCO 3 12, Na 2 HPO 4 1 and glucose 11, continuously bubbled with 95% O 2 /5% CO 2 ; pH=7.1 ± 7.2. The preparation was then transferred to the recording chamber to which the dierent working solutions and drugs were applied. Experiments were performed at room temperature (19 ± 238C) unless otherwise indicated. In some experiments the temperature in the recording chamber was controlled (+18C) throughout the experiment by means of Peltier thermoelectric devices.
Evoked endplate potentials (e.p.ps) and miniature endplate potentials (m.e.p.ps) were recorded intracellularly with conventional glass microelectrodes ®lled with 3 M KCl (10 ± 15 MO resistance). The mean quantal content of the evoked response in normal saline solution was estimated by the coef®cient of variation method (see Martin, 1966; Hubbard et al., 1969) Muscle contraction was prevented by 1.2 ± 1.8 mM (+)-tubocurarine ((+)-Tc). After impalement of a muscle ®bre, the nerve was continuously stimulated for 1 min at 0.5 Hz and then 50 ± 100 successive e.p.ps were recorded. Records were rejected if the membrane potential, V m , was 5760 mV or fell more than 5 mV during the recording period or if the 10 ± 90% e.p.p. rise time was 41 ms. No corrections for non-linear summation were made, as (+)-Tc concentration was adjusted to obtain e.p.ps of less than 4 mV (McLachlan & Martin, 1981) .
For evaluating transmitter release in low Ca 2+   -high Mg   2+ solutions the muscles were incubated in a saline solution of the following composition (mM): NaCl 137, KCl 5, CaCl 2 0.9, MgSO 4 6, NaHPO 3 12, Na 2 HPO 4 1 and glucose 11, continuously bubbled with 95% O 2 /5% CO 2 ; pH=7.1 ± 7.2. The mean quantal content (m) was evaluated by the failures method (see Martin, 1966; Hubbard et al., 1969) .
where N is the total number of successive trials (100 at 0. Presynaptic currents were recorded by means of glass microelectrodes ®lled with 2 M NaCl (5 ± 10 MO resistance) inserted, under visual control, into the perineurial sheath of small diameter nerve bundles (Mallart, 1985a) . The passive-propagating signals recorded at this location in the perineurium are not exactly`membrane currents' but they are closely related to membrane conductance changes generated both at the terminal nodes of Ranvier and at the synaptic terminals upon stimulation of the nerve. At this recording site, the currents generated at the nerve terminals are picked up with reversed polarity, so outward at the terminals will be referred to as inward and vice versa. In all cases upward de¯ections signal positivity at the recording electrode. In all the experiments, control and toxin treated records were obtained without changing the position of the electrode and once a stable recording had been achieved. The ®rst downward de¯ection (Na + signal) was used as a control of signal stability throughout the experiment (for a description of the dierent components of these currents see Brigant & Mallart, 1982; Mallart, 1985a; Penner & Dryer, 1986) . The muscles were incubated in normal saline solution in the presence of 30 ± 50 mM (+)-Tc in order to avoid any postsynaptic contribution to the records. The I Ca and I K(Ca) were obtained by adding 10 mM tetraethylammonium (TEA) and 250 mM 3,4-diaminopyridine (DAP) or 1 mM DAP, respectively, to the normal saline solution. Procaine (50 ± 200 mM) was added, when necessary, to prevent repetitive ®rings.
The nerves were stimulated by using suction electrodes coupled to a pulse generator with an associated stimulus isolation unit. The recording electrodes were connected to an Axoclamp 2A ampli®er (Axon Instruments). A distant AgAgCl electrode connected to the bath solution via an Agar bridge (Agar 3.5% in 137 mM NaCl) was used as reference. The signals were digitized (TL-1 DMA interface; Axon Instruments), stored and analysed by computer.
Values are expressed as mean+s.e.mean. Statistical signi®-cance (P values in the text and ®gure legends) was evaluated by the two tailed Student's t test for unpaired values. Data points in the concentration-response curves were ®tted by a sigmoidal concentration-response curve of the type: y=100/ (1+(10^ ( x7logIC50) n H )); where y=% of control value in the presence of the VDCC antagonist and x=log [VDCC antagonist] ; n H = Hill coecient. tical grade and purchased from Sigma (St. Louis, MO, U.S.A.). The synthetic polypeptide o-conotoxin GVIA (oCgTx) was purchased from Peptides International Co. (Louisville, KY, U.S.A.). The synthetic polypeptide o-agatoxin IVA (o-AgaIVA) was a generous gift from Dr N. Saccomano (P®zer Inc., Grotton, CT, U.S.A.). The synthetic polypeptide o-conotoxin MVIIC was purchased from RBI (Natick, MA, U.S.A.). The synthetic polypeptide o-conotoxin MVIID was a generous gift from Dr Baldomero Olivera. In all cases, both control and toxin-treated ®bres were assayed in the presence of 0.01% BSA.
Results

Eect of o-agatoxin and o-conotoxins on nerve-evoked transmitter release
As shown by the eects of the toxins on the estimated quantal content (Figure 1a ), nerve-evoked transmitter release could be almost completely abolished by the P-and Q-type VDCC antagonist (o-AgaIVA) and by the P-, Q-and N-type antagonists (o-MVIIC and o-MVIID) but was insensitive to the action of the selective N-type antagonist (o-CgTx). The strong inhibitory eect of o-AgaIVA and o-MVIIC as well as the lack of eect of o-CgTx are in agreement with previous results at the mouse neuromuscular junction (Sano et al., 1987; Protti et al., 1991; Protti & Uchitel, 1993; Bowersox et al., 1995; Hong & Chang, 1995; Wright & Angus, 1996; Katz et al., 1996) . The three toxins that target P-and Q-type VDCC greatly reduced EPP amplitudes and increased their variance (Figure 1b) . None of the toxins tested aected the resting membrane potential of the muscle ®bres which ranged between 760 and 780 mV.
Sensitivity of nerve-evoked release to the action of o-MVIIC and o-MVIID
Even though, both o-MVIIC and o-MVIID were able to reduce strongly transmitter release, this process was much more sensitive to o-MVIIC (IC 50 =39 nM) than to o-MVIID (IC 50 =1.4 mM) (Figure 2 ). The sensitivity of transmitter release to the action of o-MVIIC in the presence of 2 mM Ca 2+ and 1 mM Mg 2+ was around one order of magnitude higher than that obtained by Bowersox et al. (1995) .
Increasing the Ca 2+ concentration of the bathing medium from 2 to 10 mM in the continuous presence of 3 mM o-MVIIC induced an increase of *20 fold in the estimated m. E.p.p. amplitudes in the presence of 3 mM o-MVIIC and 2 mM Ca 2+ were 0.2+0.03 mV (n=10 endplates from 1 muscle) and increased to 3.4+0.5 mV (n=9 endplates from 1 muscle) when [Ca 2+ ] o was increased to 10 mM ( Figure 2c ). Even though the elevation of Ca 2+ caused a signi®cant increase in transmitter release, the blockade exerted by 3 mM o-MVIIC in the presence of 10 mM [Ca 2+ ] o was still very strong. In this experiment, the quantal content of the evoked response in 2 mM [Ca 2+ ] o was 78.6+8.9 (n=9 endplates from 1 muscle). In this condition, after 1 h of incubating the preparation with 3 mM o-MVIIC, the quantal content was reduced to 0.2+0.04 (n=10 endplates from 1 muscle). Elevating [Ca 2+ ] o to 10 mM in the continuous presence of 3 mM o-MVIIC caused the quantal content to increase to 4.8+1.4 (n=9 endplates from 1 muscle). The increase in release is consistent with the high sensitivity of transmitter release to variations in [Ca 2+ ] o (Dodge & Rahamimo, 1967) and with the interference of Ca 2+ with the binding of o-conotoxins to their targets (Witcher et al., 1993; Kristipati et al., 1994) . Partial inhibition of transmitter release with either o-CgTx (Kerr & Yoshikami, 1984) or o-MVIIC (Bowersox et al., 1995) has been shown to be readily reversed by increasing [Ca 2+ ] o .
Sensitivity of nerve-and K + -evoked release to the action of o-AgaIVA
In previous work at the mouse neuromuscular junction, it was shown that o-AgaIVA is able to suppress nerve-evoked release in solutions containing physiological concentrations of Ca 2+ (2 mM) with an IC 50 of around 5 ± 20 nM (Protti & Uchitel, 1993; Hong & Chang, 1995; Katz et al 1996) . It is widely known that the process of transmitter release is highly dependent on [Ca 2+ ] o and that the relationship between [Ca 2+ ] o and quantal content becomes steeper at low [Ca 2+ ] o (Dodge & Rahamimo, 1967) . Therefore, it was of interest to test whether the sensitivity of transmitter release to the action of this toxin could be modi®ed by incubating the preparation in a low Ca 2+ solution. The concentrationresponse curve obtained in the presence of 0.9 mM Ca 2+ and 6 mM Mg 2+ (Figure 3a) shows that the sensitivity of transmitter release to the action of this toxin (IC 50 =16.8 nM) was similar to that obtained in normal saline solutions in the diaphragm (Protti & Uchitel, 1993; Hong & Chang, 1995) and the levator auris (Katz et al., 1996) preparations of adult mice. Protti & Uchitel (1993) showed that K + -evoked release was also strongly reduced by 100 nM o-AgaIVA. In order to compare the potency with which o-AgaIVA was able to block nerve and K + -evoked release, we studied the eects of in- In controls, m=73+4.3 (mean+ s.e.mean, n=146 endplates from 14 muscles). Control ®bres were assayed in normal saline solution in the presence of 1.2 ± 1.8 mM (+)-tubocurarine ((+)-Tc). Treated ®bres were assayed in the same muscles after 1 h of incubation with the respective toxin. The toxins o-AgaIVA (100 nM), o-MVIID (3 mM) and o-MVIIC (1 mM) strongly reduced the evoked response while o-CgTx (5 mM) lacked any eect. Each column represents the mean+s.e.mean of data pooled from 2 ± 4 nerve-muscle preparations (numbers in parentheses are the number of endplates studied). *Student's t test (2 tailed 
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2+ channels at the mouse neuromuscular junction 1533 E. Katz et al creasing concentrations of this toxin on the K + -evoked m.e.p.p. frequency (m.e.p.p.). The concentration-response curve obtained in the presence of high K + (10 mM) in the external medium shows that the sensitivity of K + -evoked release to the action of o-AgaIVA (IC 50 =11.5 nM) was similar to that found in nerve-evoked release (Figure 3b ). In agreement with previous ®ndings (Protti & Uchitel, 1993; Hong & Chang, 1995) , spontaneous fm.e.p.p. (fm.e.p.p. obtained in normal saline solution containing 5 mM K + ), was not aected by either 100 or 300 nM o-AgaIVA (data not shown).
Reversibility of the eects of o-AgaIVA on evoked release
The eects of o-AgaIVA on P-type currents in Purkinje neurones have been shown to be irreversible unless the cells are stepped to very positive voltages while washing out the toxin (Mintz et al., 1992a) . At the mouse neuromuscular junction, it has been shown that the eects of o-AgaIVA on muscle contraction are readily reversible by washing the preparation in normal saline solution without toxin (Bowersox et al., 1995; Hong & Chang, 1995) . In contrast, the eects of this toxin on Ca 2+ presynaptic currents and on nerve-evoked release are not greatly diminished even after 40 min of incubation in normal saline solution without toxin (Protti & Uchitel, 1993 ). In the above mentioned studies, the reversibility of the eects of o-AgaIVA on muscle contraction were assayed at body temperature whereas the eects on evoked release and Ca 2+ presynaptic currents were assayed at room temperature. Therefore, it was of interest to test whether the temperature at which the assays in the presence of o-AgaIVA are carried out may account for the dierences in the reversibility of its eects at the neuromuscular junction. We evaluated the eects of o-AgaIVA on the e.p.p. quantal content and on the K + -evoked fm.e.p.p. at two dierent temperatures. The eects of o-AgaIVA on both types of release were reversed to almost their control values by washing in normal saline solution without toxin (0.6 ± 0.8 ml min 71 for 2 h) when the experiment was carried out at 31 ± 338C (Figure 4) . At this temperature, control values and those obtained after washing with normal saline solution without toxin were not signi®cantly dierent (control m versus m after toxin washout: P=0.2, n=10 endplates from 2 muscles. Control fm.e.p.p. versus fm.e.p.p. after toxin washout: P=0.7, n=35 endplates from 2 muscles). By contrast, when the experiments were carried out at 21 ± 228C the eects of o-AgaIVA persisted even after 2 h wash (Figure 4) . In this case, control values versus those obtained after washing procedure diered signi®cantly (control m versus m after toxin washout: P=0.0004, n=11 endplates from 2 muscles. Control fm.e.p.p. versus fm.e.p.p. after wash: P50.0001, n=36 endplates from 3 muscles).
In order to study whether the ionic environment could modify the reversibility of the eects of o-AgaIVA at room temperature, we evaluated the eects of toxin washout in the low Ca saline solutions (control, m=1.5+0.14, n=27 endplates from 2 muscles; treated with 30 nM o-AgaIVA, m=38+6% of control, n=27 endplates from 2 muscles) could not be reversed even after 2 h of washing out the toxin (after wash, m=43+8% of control, n=27 endplates from 2 muscles).
Eects of o-AgaIVA and o-MVIIC on the calcium presynaptic current (I Ca )
At the vertebrate neuromuscular junction, by means of the perineurial technique in the presence of K + channel blockers (10 mM TEA and 250 mM DAP), it is possible to obtain an outward current, composed of a short (*5 ms) and a long- In (a) and (b), the blockade exerted by 100 nM o-AgaIVA was evaluated in the same muscles after 1 h of incubation with the toxin. The reversibility of the eect was assayed in the same muscles after washing the preparation with the same solution without toxin for 2 h (*0.6 ± 0.8 ml min
71
). Note that at 21 ± 228C the eects of o-AgaIVA were not reversed to a great extent by washing whereas at 31 ± 338C, both types of evoked release were almost restored to their control values by this procedure. Each column represents the mean+s.e.mean of data pooled from 2 ± 3 nerve-muscle preparations (at least 5 endplates per muscle).
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2+ channels at the mouse neuromuscular junction 1535 E. Katz et al lasting component (20 ± 500 ms) that re¯ects the entry of Ca 2+ into the synaptic terminals upon depolarization (Mallart, 1985a; Penner & Dryer, 1986) . These two components were shown to dier in their sensitivity to Ca 2+ channel blockers and to stimulation frequency (Penner & Dryer, 1986; Mallart et al., 1989; Katz et al., 1995) . At the mouse neuromuscular junction, o-AgaIVA at a concentration of 100 nM was shown to reduce strongly both components of the I Ca (Protti & Uchitel, 1993; Xu & Atchinson, 1996) , whereas there is controversy regarding the eects of o-MVIIC. Lin & Lin-Shiau (1995) showed that o-MVIIC at a concentration of 1 ± 5 mM blocked only the long-lasting component of the I Ca , while Xu & Atchinson (1996) found that this toxin at 5 mM was able to block both components of the I Ca . As both o-AgaIVA and o-MVIIC were very eective in reducing transmitter release, it was of interest to evaluate further their eects on the I Ca .
The eects of applying increasing concentrations of oAgaIVA on the I Ca (Figure 5a ) showed that very low concentrations of this toxin are able to reduce substantially this current with an IC 50 that lies between 10 and 30 nM. Considering the eects of 10 nM o-AgaIVA in two other similar experiments (not illustrated), the I Ca after 20 min of incubation with this concentration of toxin was 40.8+20% (n=3 nervemuscle preparations) of the control I Ca , as evaluated by comparing the areas under the positive wave before and after the treatment. In these experiments we incubated the preparation for at least 15 min with a given concentration of o-AgaIVA and increased this concentration only after obtaining two consecutive records without detectable changes in the waveforms. The conotoxin o-MVIIC was also able to block most of the I Ca (Figure 5c ). However, the eects of this toxin had a much slower onset than those of o-AgaIVA. The slow onset of the eects of o-MVIIC are consistent with previously obtained results for the blockade of P-type currents in Purkinje neurones (McDonough et al., 1996) and for blocking the I Ca at the mouse neuromuscular junction (Xu & Atchinson, 1996) . Figure 5c illustrates the dierence between the eects of 1 mM o-MVIIC at 40 and 75 min after having added it to the bath solution.
Eects of o-AgaIVA and o-MVIIC on the calcium activated potassium current (I K(Ca) ) Calcium-activated potassium channels sensitive to TEA and charybdotoxin (ChTx) have been shown to activate as a consequence of Ca 2+ entry to the synaptic terminals upon action potential arrival and to contribute to membrane repolarization in motor synaptic terminals (Mallart, 1985b; Anderson et al., 1988) . At the frog neuromuscular junction, calcium-activated potassium channels have been shown to be spatially close and functionally related to the Ca 2+ channels involved in transmitter release (Robitaille & Charlton, 1992; Robitaille et al., 1993) . In frogs, it has been shown that while both FTX and o-CgTx are able to abolish completely transmitter release, only o-CgTx is able to block the I K(Ca) (Katz et al., 1995) . At the mouse neuromuscular junction, it was recently shown that the I K(Ca) is also involved in regulating transmitter release (Vantapour & Harvey, 1995) . Therefore it was of interest to test whether there was a correlation between the concentrations of o-AgaIVA and o-MVIIC needed to block release and those needed to block the I K(Ca) . Even though a precise quanti®cation of this current is not possible, the records in Figure 6A illustrate that 10 nM o-AgaIVA were enough to reduce substantially the I K(Ca) . This strong inhibitory eect exerted by low concentrations of o-AgaIVA on the I K(Ca) is in agreement with the eects of low concentrations of this toxin on both nerveand K + -evoked release and on the I Ca . Due to the slow onset of o-MVIIC, the eects of low toxin concentrations were dicult to evaluate with accuracy. As shown in Figure  6B , 30 and 100 nM o-MVIIC for 30 min did not strongly reduce the I K(Ca) . Higher concentrations were able to abolish completely this current ( Figure 6C ) but also after a prolonged incubation. This indicates that the eects of 30 and 100 nM o-MVIIC could be underestimated. This result is also in agreement with the long incubation times needed to block the I Ca with this toxin. The eects of o-AgaIVA and o-MVIIC on the I K(Ca) are in agreement with recently obtained results (Xu & Atchinson, 1996) .
Discussion
In the present work we re-evaluated and extended previous ®ndings in relation to the strong inhibitory eects of oAgaIVA and o-MVIIC at the mouse neuromuscular junction (Protti & Uchitel, 1993; Bowersox et al., 1995; Hong & Chang, 1995; Wright & Angus, 1995; Katz et al., 1996) . We also evaluated the eects of o-MVIID, an o-conotoxin whose target in rat brain membranes overlaps with that of o-MVIIC (Monje et al., 1993) , and found that it strongly reduces transmitter release but with less potency than o-MVIIC.
Our results show that all the Ca 2+ dependent processes evaluated in this study (nerve-and K + -evoked release and the calcium and calcium-activated potassium presynaptic currents) are highly sensitive to low concentrations of o-AgaIVA (IC 50 *10 ± 30 nM). These results are consistent with other data on the eects of o-AgaIVA at the mammalian neuromuscular junction (Protti & Uchitel, 1993; Hong & Chang, 1995; Bowersox et al., 1995; Wessler et al, 1995; Protti et al., 1996; Katz et al., 1996) and with the eects of this toxin on excitatory and inhibitory synaptic transmission in the rat CNS (Turner et al., 1992; Takahashi & Momiyama, 1993; .
Considering the non-linear relationship between external calcium and nerve-evoked transmitter release (Dodge & Rahamimo, 1967; Augustine & Charlton, 1986) , it can be expected that the IC 50 for the blockade of the current through the calcium channels at the presynaptic membrane will be higher than the IC 50 for the blockade of transmitter release, as small reductions in calcium entry would cause large reductions in the synaptic response. The IC 50 obtained for the blockade of Ptype currents by o-AgaIVA in isolated cells is *1 ± 2 nM (Mintz et al., 1992a,b; Wheeler et al., 1994a,b; Randall & Tsien, 1995) whereas the IC 50 for the blockade of Q-type currents is *90 ± 200 nM (Zhang et al., 1993; Wheeler et al., 1994a,b; Randall & Tsien, 1995) . Therefore, taking into account a power-law relationship between the quantal content of the evoked response and [Ca 2+ ] o of the type: release ! [Ca
2+
] o n , where n *4 (Dodge & Rahamimo, 1967; Augustine & Charlton, 1986) , if P-type channels are involved the IC 50 for the blockade of release should be 51 nM whereas if Q-type channels dominate, the IC 50 should be *20 nM (Wheeler et al., 1994b) . However, the discrimination between P-and Q-type channels based on the evaluation of the IC 50 for the blockade of transmitter release by o-AgaIVA may be misleading due to the complexity of the process of release and to the many factors that could lead to error in the estimation of the apparent K d for the binding of a toxin to the exocytotic channel . Unfortunately, a direct evaluation of the calcium currents through the VDCC present at the mammalian motor terminals is not feasible at present. However, the strong inhibitory eects exerted by 10 nM o-AgaIVA on the perineurial I Ca and the I K(Ca) suggest that the IC 50 for the blockade of the presynaptic VDCC present at these motor terminals may be close to this value, which is consistent with the eect of oAgaIVA on P-type currents (*100% blockade at a concentration of 100 nM; see Dunlap et al., 1995) .
Consistent with the irreversible nature of the eect of oAgaIVA on P-type currents under normal conditions (Mintz et al., 1992a) , we found that the eects of this toxin on transmitter release could not be reversed by toxin washout at room temperature. However, the blockade can be signi®cantly relieved (480%) by toxin washout at 31 ± 338C. A possible explanation for the dierence in the reversibility of the eects of this toxin at the two temperatures could be that the rate of toxin unbinding from the channel (K o ) is modi®ed not only by voltage, as shown by Mintz et al. (1992a) in Purkinje neurones, but also by temperature. As weak chemical bonds are highly sensitive to temperature, the toxin-receptor complex might be more labile at 31 ± 338C than at room temperature (Hochachka, 1991), which would facilitate the washing out of the toxin at the higher temperature. However, as both high voltage-activated calcium currents (McAllister-Williams & Kelly, 1995) and the process of transmitter release (Hubbard et al., 1971 ) have a high and complex dependence on temperature, further studies should be carried out in order to clarify the eects of temperature on the action of o-AgaIVA in this system.
With regard to the eects of o-MVIIC, we found that the sensitivity of transmitter release to the eects of this toxin was higher (IC 50 *40 nM) than those previously demonstrated (IC 50 *0.3 ± 0.5 mM) (Bowersox et al., 1995) . McDonough et al. (1996) have shown that the potency for the blockade of both Ptype channels in Purkinje neurones and N-type channels in superior cervicle ganglion (SCG) neurones by o-MVIIC is very sensitive to variations in the ionic composition of the extracellular medium. These authors show that the IC 50 for the blockade of P-type currents increased from 5 to 50 nM by increasing the Ba 2+ concentration in the extracellular medium from 2 to 5 mM. This evidence, together with interference of divalent cations with the binding of o-conotoxins (Witcher et al., 1993; Kristipati et al., 1994) , suggest that the dierences found in the IC 50 for the blockade of transmitter release could be accounted for by the fact that we used a lower concentration of divalent cations in the extracellular medium to study the concentration-response eects of this toxin than those used by Bowersox et al. (1995) . In addition, the concentration-response curve obtained by Bowersox et al. (1995) was performed by incubating the preparation with o-MVIIC for 30 min whereas in our experiments we used incubation times of more than 1 h.
It was previously shown that o-MVIIC, at high concentrations (5 mM), could only block the slow component of the I Ca and that it blocked transmitter release only partially if this was elicited in the presence of the voltage-dependent K + channel blocker DAP (Lin & Lin-Shiau, 1995) . Considering these partial eects, these authors proposed that o-MVIIC targets only one population of the multiple channels that might be involved in controlling release at the mouse neuromuscular junction. We found that the eect of this toxin, except for the prolonged time necessary to achieve its maximal inhibition, was similar to the strong inhibitory eect exerted by o-AgaI-VA on both outward components (see also Protti & Uchitel, 1993) . The long incubation times needed to achieve maximal blockade with o-MVIIC are consistent with those obtained for the blockade of P-type currents in Purkinje neurones (McDonough et al., 1996) . The fact that this toxin was able to abolish completely the I Ca , the I K(Ca) and the transmitter release process argue against the hypothesis proposed by Lin & LinShiau (1995) . Our results do not exclude the possibility that multiple channel types coexist at the mouse neuromuscular junction and that, under certain conditions, more than one type of channel may be controlling transmitter release (Katz et al., 1996) as is known to occur at central synapses (Takahashi & Momiyama, 1993; Mintz et al., 1995) .
An interesting ®nding was that the sensitivity of transmitter release to the action of o-MVIID (IC 50 =1.4 mM) was much less than that observed upon incubation with o-MVIIC (IC 50 =39 nM). This dierence was unexpected due to the similar potency with which both synthetic conotoxins are able to displace [ 125 I]-o-conotoxin MVIIC from the high anity`non-N' site on rat brain membranes (Monje et al., 1993) . This result could be indicating that assay conditions might dierentially aect the potency of these two toxins or that the binding of each toxin to this site does not aect the functioning of the channel with equal potency. Alternatively, it may be showing that the VDCC present at these motor terminals may be slightly dierent from the VDCC targeted by o-MVIIC and o-MVIID on rat brain membranes.
In summary, this work shows the strong inhibitory eects exerted by the toxins that target P and Q type VDCC on transmitter release. The almost complete blockade of the I Ca and I K(Ca) presynaptic currents exerted by o-AgaIVA and o-MVIIC are consistent with their eects on transmitter release. From these results we can conclude that at the mouse neuromuscular junction Ca 2+ entry from the extracellular space is accomplished mainly through P (and/or Q) type VDCC which are highly sensitive to both o-AgaIVA and o-MVIIC. To discern whether this is a homogeneous or a heterogeneous population of VDCC will need further evaluation with dierent techniques, in order to assess more directly both the biophysical and pharmacological characteristics of the currents through the channels involved in transmitter release at these synaptic terminals.
